Changing the trajectory of cancer takes focus — at scale

Over the past several decades, the oncology community has made tremendous strides in fighting cancer. But ultimately changing the trajectory of the disease for patients will take focus, at scale. We must continue to identify where we can make the biggest impact, and then go all in. Read on to find out how Pfizer Oncology is working with partners across the oncology ecosystem to translate the best science into cutting-edge treatments.